brand brand
Collapse

Hereditary Transthyretin Amyloidosis - Transthyretin Amyloidosis Treatment Market Statistics

The global hereditary transthyretin amyloidosis transthyretin amyloidosis treatment market size was valued at US$ 2,985.8 million in 2024 and is estimated to grow at a compound annual growth rate (CAGR) of 13.9% from 2024 to 2030.

  • Select file type

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Global transthyretin amyloidosis treatment market statistics, 2018-2030 (US$M)

Related Statistics

Global transthyretin amyloidosis treatment market statistics, by targeted therapy, 2018-2030 (USD Million)

Hereditary transthyretin amyloidosis - Transthyretin amyloidosis treatment market highlights

  • The global hereditary transthyretin amyloidosis segment generated a revenue of USD 2,985.8 million in 2024 and is expected to reach USD 7,450.7 million by 2030.
  • The market is expected to grow at a CAGR (2025 - 2030) of 13.9% by 2030.
  • In terms of region, North America was the largest revenue generating market in 2024.
  • Country-wise, UK is expected to register the highest CAGR from 2025 to 2030.

Market summary

Market revenue in 2024USD 2,985.8 million
Market revenue in 2030USD 7,450.7 million
Growth rate13.9% (CAGR from 2025 to 2030)
Historical data covered2018 - 2023
Base year for estimation2024
Forecast period covered2025 - 2030
Quantitative unitsRevenue in USD million

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
ANALYST CALLBACK

Transthyretin Amyloidosis Treatment Market Scope

Transthyretin amyloidosis treatment market segmentation & scope
Therapy
Targeted Therapy
Vyndaqel/ Vyndamax
Onpattro
Amvuttra
Tegsedi
Wainua
Supportive Therapy
Pipeline Therapy
Type
ATTR with Polyneuropathy (ATTR-PN)
ATTR with Cardiomyopathy (ATTR-CM)
Disease Type
Hereditary Transthyretin Amyloidosis
Polyneuropathy
Cardiomyopathy
Mixed Type
Wild Type Amyloidosis
Distribution Channel
Hospital Pharmacies
Specialty Pharmacies
Retail Pharmacies
Online Pharmacies
Regions
Latin America
Europe
North America
Middle East & Africa
Asia Pacific
Countries
U.S.
Canada
Germany
France
Italy
Spain
UK
Japan
China
Brazil
South Africa
Mexico
Denmark
Norway
Sweden
India
Australia
South Korea
Thailand
Argentina
Saudi Arabia
UAE
Kuwait
report
Transthyretin Amyloidosis Treatment Market Outlook
  • PDF
  • HTML
  • PPT
  • -
Everything on Transthyretin Amyloidosis Treatment Market Outlook in one document: edited and divided into chapters, including detailed references.

Related industry reports

Global Huntingtons Disease Treatment Market Outlook, 2022-2030

Global Amyloidosis Treatment Market Outlook, 2021-2028

Global Fabry Disease Treatment Market Outlook, 2020-2027

Global Hereditary Angioedema Therapeutics Market, 2022-2030

Global Rare Diseases Treatment Market Outlook, 2021-2030

Related Regional Reports

North America Transthyretin Amyloidosis Treatment Market Outlook, 2024-2030

Europe Transthyretin Amyloidosis Treatment Market Outlook, 2024-2030

Asia Pacific Transthyretin Amyloidosis Treatment Market Outlook, 2024-2030

Latin America Transthyretin Amyloidosis Treatment Market Outlook, 2024-2030

MEA Transthyretin Amyloidosis Treatment Market Outlook, 2024-2030

U.S. Transthyretin Amyloidosis Treatment Market Outlook, 2024-2030

Canada Transthyretin Amyloidosis Treatment Market Outlook, 2024-2030

Germany Transthyretin Amyloidosis Treatment Market Outlook, 2024-2030

France Transthyretin Amyloidosis Treatment Market Outlook, 2024-2030

Italy Transthyretin Amyloidosis Treatment Market Outlook, 2024-2030

Spain Transthyretin Amyloidosis Treatment Market Outlook, 2024-2030

Russia Transthyretin Amyloidosis Treatment Market Outlook, 2021-2028

Japan Transthyretin Amyloidosis Treatment Market Outlook, 2024-2030

China Transthyretin Amyloidosis Treatment Market Outlook, 2024-2030

Brazil Transthyretin Amyloidosis Treatment Market Outlook, 2024-2030

South Africa Transthyretin Amyloidosis Treatment Market Outlook, 2024-2030

UK Transthyretin Amyloidosis Treatment Market Outlook, 2024-2030

Mexico Transthyretin Amyloidosis Treatment Market Outlook, 2024-2030

Denmark Transthyretin Amyloidosis Treatment Market Outlook, 2024-2030

Sweden Transthyretin Amyloidosis Treatment Market Outlook, 2024-2030

Norway Transthyretin Amyloidosis Treatment Market Outlook, 2024-2030

India Transthyretin Amyloidosis Treatment Market Outlook, 2024-2030

Australia Transthyretin Amyloidosis Treatment Market Outlook, 2024-2030

South Korea Transthyretin Amyloidosis Treatment Market Outlook, 2024-2030

Thailand Transthyretin Amyloidosis Treatment Market Outlook, 2024-2030

Argentina Transthyretin Amyloidosis Treatment Market Outlook, 2024-2030

Saudi Arabia Transthyretin Amyloidosis Treatment Market Outlook, 2024-2030

UAE Transthyretin Amyloidosis Treatment Market Outlook, 2024-2030

Kuwait Transthyretin Amyloidosis Treatment Market Outlook, 2024-2030

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online